However, copy-number variation analyses showed that MPC2 was frequently amplified in a specific molecular subtype of HCC termed as the “mixed group” subtype characterized by higher variability in metabolic activity, compared to the quiescent subtype defined by low metabolic activity and cholesterol subtype characterized by reliance on cholesterol synthesis pathways [113]. This evidence concerns the gene MPC2 and hepatocellular carcinoma.